Moderna, a global healthcare company, has a market cap of $16.9 billion and revenues of $3.1 billion.
Moderna shares are up 1.7% since December 31, 2018.
Moderna stock was up 1% on Thursday.
As a healthcare company with a core product and service segment, Moderna has long been an attractive investment opportunity for investors.
The company is focused on developing innovative solutions for the healthcare sector, including its own healthcare and specialty products, as well as partnerships with healthcare institutions and pharmaceutical companies.
The stock has gained a significant number of shares since its recent trading halt in the wake of the 2016 Las Vegas mass shooting, which claimed the lives of 58 people.
Moderna has a long track record of high stock prices, with a market capitalization of $30 billion, according to data compiled by S&P Global Market Intelligence.
The last time Moderna’s stock was at such a high price was in March 2020, when it reached a high of $21.35 per share.
According to the S&s Global Healthcare Index, Modernan’s market cap is now $52.2 billion, which is down about 9% from the same period last year.
Since its inception in 2004, Moderni has expanded rapidly, taking on a broad spectrum of business sectors.
Moderni was the first provider of healthcare equipment and technology to offer advanced health care and personal care services, and it is a leader in technology and healthcare solutions.
Moderni was founded by Dr. James M. O’Brien and Dr. Robert F. Gee, and is headquartered in Houston, Texas.